Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: December 2009

Chapter 3 - Nutrition

from Section 1 - Introduction

Summary

The most important characteristic of a healthy diet is balance of food types, and of intake and output. Low protein intake is associated with a higher risk of bone fracture. There is controversy about whether high animal protein intake increases the risk of fractures in women. Menopausal women are at increased risk for osteoporosis, especially if they are Caucasian and/or thin. The best calcium source is dairy products. Three servings provide the recommended daily allowance of 1000 mg. With fewer women taking hormone replacement therapy, more women are looking for alternatives to control menopausal symptoms, particularly hot flashes. The type of natural product most commonly used for menopausal symptoms are phytoestrogens or plant estrogens. Eating disorders are most commonly associated with younger women: teenagers and young adults. The recommended diet for people with diabetes should contain carbohydrate, protein, and fat in reasonable proportions.

Related content

Powered by UNSILO

References

1. My Pyramid Background, http://www.mypyramid.gov, accessed 1/07.
2. American Institute for Cancer Research. The American Plate, http://aicr.convio.net/site/PageServer?pagename=pub_nap_index_21, accessed 1/07.
3. FuchsC. S., GiovannucciE. L., ColdtzG. A. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999; 340, 169–176.
4. TrichopoulouA., OrfanosP., NoratT., et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. Br Med J 2005; 330, 991. doi:10.1136/bmj.38415.644155.8F.
5. Dawson-HughesB. Interaction of dietary calcium and protein in bone health in humans. J Nutr 2005; 133, 852S–854S.
6. BonjourJ.-P. Dietary protein: an essential nutrient for bone health. J Am Coll Nutr 2005; 24, 526S–536S.
7. WolkA., MansonJ. E., StampferM. J., et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. J Am Med Assoc 1999; 281, 1998–2004.
8. WeickertM. O., MöhligM., SchöflC., et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006; 29, 775–780.
9. PereiraM. A., O'ReillyE., AugustssonK., et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004; 164, 370–376.
10. Van HornL. Fiber, lipids, and coronary heart disease: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1997; 95, 2701–2704.
11. McKeownN. M., MeigsJ. B., LiuS., WilsonP. W. F., JacquesP. F. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002; 76, 390–398.
12. Wylie-RosettJ., Segal-IsaacsonC. J., Segal-IsaacsonA. Carbohydrates and increases in obesity: does the type of carbohydrate make a difference?Obes Res 2004; 12, 124S–129S.
13. CarletonR. A., DwyerJ., FinbergL., et al. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 1991; 83, 2154–2232.
14. American Dietetic Association. Disorders of Lipid Metabolism Evidence-Based Nutrition Practice Guideline, Executive Summary Recommendations, Evidence Analysis Library, http://www.adaevidencelibrary.com, accessed 12/06.
15. NIH. Optimal Calcium Intake. NIH Consensus Statement Online 1994 June 6–8; 12(4), 1–31, http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat4.chapter.13595.
16. MaserejianN. N., JoshipuraK. J., RosnerB. A., GiovannucciE., ZavrasA. I. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 2006; 15(4), 774–781.
17. Hin-PengL. Diet and breast cancer: an epidemiologist's perspective. Crit Rev Oncol Hematol 1998; 28(2), 115–119.
18. EngelL. S., ChowW. H., VaughanT. L., GammonM. D., RischH. A., StanfordJ. L., SchoenbergJ. B., MayneS. T., DubrowR., RotterdamH., WestA. B., BlaserM., BlotW. J., Gail M. H., Fraumeni J. F. Jr. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95(18), 1404–1413.
19. MontaltoG., CervelloM., GiannitrapaniL., DantonaF., TerranovaA., CastagnettaL. A.Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 2002; 963, 13–20.
20. BrownL. M., SilvermanD. T., PotternL. M., SchoenbergJ. B., GreenbergR. S., SwansonG. M., LiffJ. M., SchwartzA. G., HayesR. B., BlotW. J., et al. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994; 5(4), 333–340.
21. GammonM. D., SchoenbergJ. B., AhsanH., RischH. A., VaughanT. L., ChowW. H., RotterdamH., WestA. B., DubrowR., StanfordJ. L., MayneS. T., FarrowD. C., NiwaS., BlotW. J., FraumeniJ. F. Jr. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89(17), 1277–1284.
22. PischonT., LahmannP. H., BoeingH., FriedenreichC., NoratT., TjonnelandA., et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98(13), 920–931.
23. McPhersonK., SteelC. M., DixonJ. M., ABC of breast diseases. Breast cancer – epidemiology, risk factors, and genetics. Br Med J 2000; 321(7261), 624–628.
24. ChowW. H., BlotW. J., VaughanT. L., RischH. A., GammonM. D., StanfordJ. L.DubrowR., SchoenbergJ. B., MayneS. T., FarrowD. C., AhsanH., WestA. B., RotterdamH., NiwaS., FraumeniJ. F. Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90(2), 150–155.
25. LagergrenJ., BergstromR., NyrenO. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130(11), 883–890.
26. WuA. H., WanP., BernsteinL. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12(8), 721–732.
27. CrewK. D., NeugutA. I. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004; 31(4), 450–464.
28. WeiderpassE., PerssonI., AdamiH. O., MagnussonC., LindgrenA., BaronJ. A. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11(2), 185–192.
29. De LucaL. M., RossS. A.Beta-carotene increases lung cancer incidence in cigarette smokers. Nutr Rev 1996; 54(6), 178–180.
30. CroninK. A., Krebs-SmithS. M., FeuerE. J., TroianoR. P., Ballard-Barbash R. Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States). Cancer Causes Control 2001; 12(4), 305–316.
31. TerryM. B., GaudetM. M., GammonM. D. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12(2), 111–127.
32. American Cancer Society. Common Questions about Diet and Cancer, http://www.cancer.org/docroot/PED/content/PED_3_2X_Common_ Questions_About_Diet_and_Cancer.asp?sitearea=PED, accessed 12/06.
33. American Cancer Society. Cancer Prevention and Early Detection – Facts and Figures, 2005, http://www.cancer.org/downloads/STT/CPED2005v5PWSecured.pdf, accessed 12/06.
34. El-AgameyA., LoweG. M., McGarveyD. J., MortensenA., PhillipD. M., TruscottT. G., YoungA. J. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 2004; 430(1), 37–48.
35. Wactawski-WendeJ., KotchenJ. M., AndersonG. L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354(7), 752–754.
36. HoltP. R., BresalierR. S, MaC. K., LiuK. F.et al. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 2006; 106(2), 287–296.
37. CarrollD. G. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 2006; 73(3), 457–464.
38. JellinJ. M., GregoryP. J., BatzF., HitchensK., et al., eds. Natural medicines in clinical management of menopausal symptoms. Pharmacist's Letter/Prescriber's Letter, Natural Medicines Comprehensive Database. www.naturaldatabase.com, accessed 11/06.
39. Agency for Healthcare Research and Quality. Management of menopause-related symptoms. Summary, Evidence Report/Technology Assessment: Number 120. AHRQ Publication No. 05-E016–1, March 2005. Rockville, MD: AHRQ, 2005, http://www.ahrq.gov/clinic/epcsums/menosum.htm, acessed 11/06.
40. ScottG. N. Soy for preventing aging effects in older women. Prescribers lett 2004; 20, 200914.
41. TiceJ. A., EttingerB., EnsrudK., et al. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. J Am Med Assoc 2003; 290(2), 207–214.
42. DodinS., LemayA., JacquesH., et al. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005; 90(3), 1390–1397.
43. North American Menopause Society. Mother Nature's Treatment for Hot Flashes, Menopause Flashes 2006, http://www.menopause.org/hotflashes.htm, accessed 1/07.
44. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004; 11(1), 11–33.
45. HedleyA. A., OgdenC. L., JohnsonC. L., CarrollM. D., CurtinL. R., FlegalK. M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. J Am Med Assoc 2004; 291, 2847–2850.
46. Ramlo-HalstedB. A., EdelmanS. V. The natural history of type 2 diabetes: implications for clinical practice. Primary Care Clin Office Pract 1999; 26, 771–789.
47. McTigueK. M., HessR., ZiourasJ. Obesity in older adults: a systematic review of the evidence for diagnosis and treatment. Obesity 2006; 14, 1485–1497.
48. LyznickiJ. M., YoungD. C., RiggsJ. A., DavisR. M. Obesity: assessment and management in primary care. Am Fam Physician 2001; 65, 2185–2196.
49. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, NIH Publication no. 98–4083, September 1998, http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf, accessed 1/07.
50. USDA. The 1987–88 Nationwide Food Consumption Survey (NFCS), http://www.ars.usda.gov/Services/docs.htm?docid=7804, accessed 12/06.
51. ChoS., DietrichM., BrownC. J. P., ClarkC. A., BlockG. The effect of breakfast type on total daily energy intake and body mass index: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Am Coll Nutr 2003; 22(4), 296–302.
52. MaY., BertoneE. R., StanekE. J., ReedG. W., HebertJ. R., CohenN. L., MerriamP. A., OckeneI. S.Association between eating patterns and obesity in a free-living US adult population. Am J Epidemiol 2003; 158(1), 85–92.
53. SongW. O., ChunO. K., ObayashiS., ChoS., ChungC. E.Is consumption of breakfast associated with body mass index in US adults?J Am Diet Assoc 2005; 105, 1373–1382.
54. MartinA., NormandS., SothierM., PeyratJ., Louche-PelissierC., LavilleM. Is advice for breakfast consumption justified? Results from a short-term dietary and metabolic experiment in young healthy men. Br J Nutr 2000; 84, 337–344.
55. SchlundtD. G., HillJ. O., SbroccoT., Pope-CordleJ., SharpT. The role of breakfast in the treatment of obesity: a randomized clinical trial. Am J Clin Nutr 1992; 55, 645–651.
56. WyattH. R., GrunwaldG. K., MoscaC. L., KlemM. L., WingR. R., HillJ. O.Long-term weight loss and breakfast in subjects in the National Weight Control Registry. Obesity Res 2002; 10(2), 78–82.
57. American Dietetic Association. Eating frequency and patterns, Evidence Analysis Library, http://www.adaevidencelibrary.com/, accessed 10/06.
58. LaHayeS. A., HollettP. M., VyselaarJ. R., ShalchiM., LaheyK. A., DayA. G.Comparison between a low glycemic load diet and a Canada Food Guide diet in cardiac rehabilitation patients in Ontario. Can J Cardiol 2005; 21(6), 489–494.
59. BoucheC., RizkallaS. W., LuoJ., VidalH., VeroneseA., PacherN., FouquetC., LangV., SlamaG. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 2002; 25, 822–828.
60. BlanckH. M., KhanL. K., SerdulaM. K. Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal. Prev Med 2004; 39, 1243–1248.
61. KrugerJ., GaluskaD. A., SerdulaM. K., et al. Attempting to lose weight: specific practices among US adults. Am J Prev Med 2004; 26(5), 402–406.
62. American Dietetic Association. Evidence Library, www.adaevidencelibrary.com/, accessed 11/06.
63. American Dietetic Association. Adult weight management, low carbohydrate diets, Evidence Analysis Library, http://www.adaevidencelibrary.com/conclusion.cfm?conclusion_statement_id=250234, accessed 12/06.
64. American Dietetic Association. Adult weight management, meal replacement diets, Evidence Analysis Library, http://www.adaevidencelibrary.com/conclusion.cfm?conclusion_statement_id=250237, accessed 12/06.
65. FisherM. The course and outcome of eating disorders in adults and in adolescents: a review. Adolesc Med State Art Rev 2003; 14, 149–158.
66. American Diabetes Association. Position statement: standards of medical care in diabetes – 2006. Diabetes Care 2006; 29, S4–S42.
67. CryerP. E., FisherJ. N., ShamoonH. Hypoglycemia (technical review). Diabetes Care 1994; 17, 734–755.
68. MoscaL., AppelL. J., et al. AHA Scientific Statement. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109, 672–693.
69. KatanM. B., ZockP. L., MensinkR. P. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 1994; 60(suppl), 1017S–1022S.
70. MozaffarianD., KatanM. B., AscherioA., et al. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354(15), 1601–1613.
71. HuF. B., WillettW. C.Optimal diets for prevention of coronary heart disease. J Am Med Assoc 2002; 288, 2569–2578.
72. O'MaraN. B. Fish and fish oil and cardiovascular disease. Prescriber's Lett 2002; 9, 180510.
73. American Heart Association. Fish and Omega-3 Fatty Acids, http://www.americanheart.org/presenter.jhtml?identifier=4632, accessed 12/06.
74. GavaganT. Cardiovascular disease. Prim Care 2002; 29(2), 323–338. http://home.mdconsult.com/das/journal/view/24073294/N/12597644?ja=288950&PAGE=1.html&sid=145542255&source=, accessed 10/06.
75. JellinJ. M., GregoryP. J., BatzF., HitchensK., et al. eds. Natural medicines in clinical management of hyperlipidemia. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty, updated 8/16/06. www.naturaldatabase.com, accessed 8/21/06.
76. American Dietetic Association. Disorders of lipid metabolism evidence based nutrition practice guideline, Evidence Analysis Library, www.adaevidencelibrary.com.
77. VollmerW. M., SacksF. M., ArdJ., et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASHG-Sodium trial. Ann Intern Med 2001; 135, 1019–1028.
78. SacksF. M., SvetkeyL. P., VollmerW. M., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344, 3–10.
79. KeevilJ., SteinJ. H., McBrideP. E. Cardiovascular disease prevention. Prim Care 2002; 29(3). http://home.mdconsult.com/das/journal/view/24073294/N/12597673?ja=295124&PAGE=1.html&sid=145544570 &source=, accessed 11/02.
81. WheltonP. K., HeJ., CutlerJ. A., et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. J Am Med Assoc 1997; 277, 1624–1632.
82. Van MierloL. A. J., ArendsL. R., StreppelM. T., et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertension 2006; 20, 571–580.
83. SongY., SessoH. D., MansonJ. E. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10 year follow-up study. Am J Cardiol 2006; 98(12), 1616–1621.
84. SacksF. M., WillettW. C., SmithA., BrownL. E., RosnerB., MooreT. J. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension 1998; 31, 131–138.
85. XinX., HeJ., FrontiniM. F. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001; 38, 1112–1117.
86. AppelL. J., MooreT. J., ObarzanekE., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336, 1117–1124.
87. WheltonP. K., HeJ., AppelL. J., et al. Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. J Am Med Assoc 2002; 288, 1882–1888.
88. BergerA. M., Clark-SnowR. A.Adverse effects of treatment. In DevitaV. T., HellmanS., RosenbergS. A. eds., Cancer Principles and Practice of Oncology. Philadelphia, PA: Lippincott-Raven, 1997, p. 2705.
89. RavascoP. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 2005; 9(Suppl 2), S84–S91.
90. de GodoyI., DonahoeM., CalhounW. J., et al. Elevated TNF production by peripheral blood monocytes of weight losing COPD patients. Am J Respir Crit Care Med 1996; 153, 633–637.
91. FerreiraI. M., BrooksD., LacasseY., et al. Nutritional support for individuals with COPD: a metaanalysis. Chest 2000; 117, 672–678.
92. FiaccadoriE., CoffriniE., RondaN., et al. A preliminary report on the effects of malnutrition on skeletal muscle composition in chronic obstructive pulmonary disease. In FerrantiR. D., RampullaC., FracchiaC., AmbrosinoN., eds., Nutrition and Ventilatory Function, Verona: Bi and GI Publishers, 1992.
93. FuldJ. P., KilduffL. P., NederJ. A., PitsiladisY., LeanM. E., WardS. A., CottonM. M.Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005; 60(7), 531–537.
94. ScholsA. M., SoetersP. B., MostertR., et al. Physiologic effects of nutritional support anabolic steroid in patients with obstructive pulmonary disease: a placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152, 1268–1274.
95. GriffithsT. L., ProudD. Creatine supplementation as an exercise performance enhancer for patients with COPD? An idea to run with. Thorax 2005; 60(7), 525–526.
96. BerryJ. K., BaumC. L.Malnutrition in chronic obstructive pulmonary disease: adding insult to injury. AACN Clin Issues 2001; 12, 210–219.
97. SchwartzJ. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr 2000; 71(Suppl), 393S–396S.
98. MatsuyamaW., MitsuyamaH., WatanabeM., OonakaharaK., HigashimotoI., OsameM., ArimuraK. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest 2005; 128(6), 3817–3827.
99. AllenJ. The therapeutic use of fish oil. Prescriber's Lett 1997; 4, 130624.
100. SmitH. A., GrievinkL., TabakC. Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc Nutr Soc 1999; 58, 309–319.
101. MessierS. P., LoeserR. F., MillerG. D., et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum 2004; 50(5), 1501–1510.
102. LyuL.-C., HsuC.-Y., YehC.-Y., et al. A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr 2003; 78, 690–701.
103. ChoiH. K., AtkinsonK., KarlsonE. W., et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350, 1093–1103.
104. ScottG. N.Natural alternatives to rofecoxib (Vioxx). Pharmacist's Lett/Prescriber's Lett 2004; 20(12), 201210.
105. CleggD. O., RedaD. J., HarrisC. L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354(8), 795–808.
106. JellinJ. M., GregoryP. J., BatzF., HitchensK., et al. eds. Natural medicines in clinical management of osteoarthritis. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty, updated 8/16/06. www.naturaldatabase.com, accessed 8/21/06.
107. FPIN's clinical inquiries: glucosamine and chondroitin for osteoarthritis. Am Fam Physician 2006; 73(7), 1245–1247.